Evaxion Biotech A/S (EVAX) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Evaxion Biotech A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-3.94
Burn Risk
P/B Ratio
1.79
Strong
WeakModerateStrong
Earnings Yield
-25.21%
Yield Gap
Profitability Health
2025Return on Equity
-45.23%
Weak
WeakModerateStrong
Operating Margin
-122.66%
Weak
WeakModerateStrong
Net Profit Margin
-102.38%
Weak
WeakModerateStrong
Growth Indicators
2025Revenue Growth
125.12%
Strong
WeakModerateStrong
Net Income Growth
27.07%
Strong
WeakModerateStrong
EPS Growth
87.65%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
5.85
Strong
WeakModerateStrong
Quick Ratio
5.85
Strong
WeakModerateStrong
Asset Turnover
0.27x
Weak
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-21.78%
Weak
WeakModerateStrong
EV / Free Cash Flow
-2.23x
Strong
WeakModerateStrong
Net Debt / EBITDA
2.21x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.933
Moderate
WeakModerateStrong
Return on Invested Capital
-33.44%
Weak
WeakModerateStrong
Cash Conversion Cycle
50.96 days
Weak
WeakModerateStrong
Fortress screener guardrails
0/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for EVAX.
View Financial Statements